维普期刊资源整合服务平台（V6.5）

118篇 您的检索式：作者名="Navari RM"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Comparison of the open skull and cranial window preparations in the study of the cerebral microcirculation显示文摘	Navari RM Wei EP Kontos HA	1978	Microvas Res1978，16，3：	1
2	Antiemetic control: toward a new standard of care for emetogenic chemotherapy 显示文摘	Navari RM	2009	Expert Opin Pharmacother2009，10，4：	1
3	Pharmacological management of chemotherapy-in- duced nausea and vomiting: focus on recent developments显示文摘	NAVARI RM	2009	Drugs2009，69，5：	1
4	Olanzapine versus aprepitant for the prevention of chemotherapy - induced nausea and vomiting : A ran- domized phase Ⅲ triM显示文摘	Navari RM Gray SE Kerr AC	2011	J Support Oncol2011，9，：	1
5	Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-in- duced nausea and vomiting (CINV) 显示文摘	Navari RM	2014	Drug Des Devel Ther2014，17，9：	1
6	Management of chemotherapy-induced nausea and vomiting, focus on newer agents and new uses for ol- der agents显示文摘	Navari RM	2013	Druges2013，73，3：	1
7	Mycobacterial infections in marrow transplant patients显示文摘	Navari RM Sullivan KM Springmeyer SC	1983	Transplantation1983，36，5：	1
8	Management of chemotherapy-induced nausea andvomiting : focus on newer agents and new uses for older agents显示文摘	NAVARI RM	2013	Drugs2013，73，3：	1
9	Olanzapine versus aprepi- rant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase IH trial 显示文摘	Navari RM Gray SE Kerr AC	2011	J Support Oncol2011，9，5：	1
10	Casopitant, a neurokinin - 1 receptor antagonist with anti - emetic and anti - nausea activities 显示文摘	Navari RM	2008	Curr Opin Investig Drugs2008，9，7：	1
11	Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting:a randomized phaseⅢtrial显示文摘	Navari RM Gray SE Kerr AC	2011	Support Oncol2011，9，5：	1
12	Treatment of cancer - related anorexia with olanzapine and megestrol acetate 显示文摘	Navari RM Brenner MC	2008	J Clin Oncol2008，26，15：	1
13	The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy显示文摘	Navari RM Nagy CK Gray SE	2013	Support Care Cancer2013，21，6：	1
14	Treatment of cancer-related anorexiawith olanzapine and megestrol acetate:a randomized trial显示文摘	Navari RM Brenner MC	2010	Support Care Cancer2010，18，8：	1
15	The use of olanzapine versus metoclo- pramide for the treatment of breakthrough chemotherapy - induced nausea and vomiting in patients receiving highly emetogenic chemo- therapy 显示文摘	Navari RM Nagy CK Gray SE	2013	Support Care Cancer2013，21，6：	1
16	A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Ontology Group study显示文摘	Passik SD Navari RM Jung SH	2004	Cancer Invest2004，22，3：	1
17	Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomit- ing: a randomized phase III trial显示文摘	Navari RM Gray SE Kerr AC	2011	J Sup- port Oncol2011，9，5：	1
18	The use of olanzapine versus metoclopramide for the treatment of breakthrough chemothera- py-induced nausea and vomiting in pati- ents receiving highly emetogenic chemo- therapy显示文摘	Navari RM Nagy CK Gray SE	2013	Support Care Cancer2013，21，6：	1
19	Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist显示文摘	Reinhardt RR Gralla RJ	1999	N hngl J Med1999，340，：	1
20	A phase I trial of olanzapine (Zyprexa) for the prevention of de\|ayed emesis in cancer patients: a Hoosier Oncology Group study显示文摘	Passik SD Navari RM Jung SH	2004	Cancer In-vest2004，22，3：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示